Premium
Urologix Inc (CE) (ULGX)
USOTC
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
The poster "Cost-Effectiveness Markov Model Comparing High- and Low-Energy Transurethral Microwave Therapy for Benign Prostatic Hyperplasia" will be presented Tuesday morning, May 20th, by Dr...
Third quarter revenue totaled $3.4 million Cash balance of $816,000 as of March 31, 2014 Annualized expenses reduced by over $4.0 million since January 1, 2014 MINNEAPOLIS, May 6...
MINNEAPOLIS, April 30, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB:ULGX) will host a conference call to present fiscal year 2014 third quarter results on Tuesday, May 6, 2014 at 4:00...
Third quarter revenue totaled $3.4 million Cash balance of $816 thousand as of March 31, 2014 MINNEAPOLIS, April 10, 2014 (GLOBE NEWSWIRE) -- Urologix®, Inc...
MINNEAPOLIS, July 1, 2013 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB:ULGX), the leading provider of in-office BPH therapy, announces the restructuring of payment obligations to Medtronic related...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 1095 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0401 | 1.0E-6 | 3781 | 9.699E-5 | CS |
| 26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0401 | 1.0E-6 | 3258 | 8.057E-5 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0401 | 1.0E-6 | 2414 | 8.068E-5 | CS |
| 156 | 0 | 0 | 0.0001 | 0.0401 | 1.0E-6 | 9518 | 0.00010714 | CS |
| 260 | -0.0033 | -97.0588235294 | 0.0034 | 0.0401 | 1.0E-6 | 65757 | 0.00709399 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
